Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 1536489A

Drug Profile

GSK 1536489A

Alternative Names: FluLaval; FluLaval trivalent; FluLaval-YB; FluSF; Fluviral; Fluviral-S-F; Fluviral-S/F; GSK-1536489A; GSK-1557482A; Influenza vaccine split virion inactivated - GlaxoSmithKline; SPD-707

Latest Information Update: 04 Nov 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ID Biomedical Corporation
  • Developer Folia Biotech; GlaxoSmithKline; ID Biomedical Corporation; Pan-Provincial Vaccine Enterprise
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Influenza-virus-infections(Prevention, Adjuvant therapy) in Canada (IM, Injection)
  • 01 Apr 2014 Phase-I clinical trials in Influenza virus infections (adjuvant therapy, prevention) in Canada (IM)
  • 19 Aug 2013 US FDA expands approval of FluLaval® for use in children aged 3 years and older, and adults in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top